Devicemaker Kai Medical to merge with biotech Novogen

Hawaii's Kai Medical says it will merge with Australian biotech Novogen ($NVGN), weeks after revealing agreements to sell its apnea therapy devices in Europe, Australia, Hong Kong and elsewhere. Financial details aren't being disclosed, but shareholders at Novogen are expected to vote on the matter in mid-September, the companies stated. Kai Medical, which is based in Honolulu, also makes wireless devices designed to measure and monitor respiration. Once the merger is complete, the combined company will be called Kai Medical Holdings. Story

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.